Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.
The objective of this study is to demonstrate the short-term multiple dose efficacy and safety of HKT-500 in subjects with pain caused by mild to moderate osteoarthritis of the knee. The goal of the study is to gather additional information about the analgesic efficacy and safety of repeated, 24-hour applications of 2 HKT-500 patches per knee for a total of 28 days in subjects with pain caused by mild to moderate osteoarthritis of the knee.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ketoprofen Patch | Experimental | Treatment with experimental drug |
|
| Placebo Patch | Placebo Comparator | Treatment with placebo drug |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ketoprofen Patch | Drug | 2 topical patches applied once daily for 28 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from the baseline of the WOMAC pain subscale score at Visit 6 (Day 14 ± 2 days) | 14 days ± 2 days |
| Measure | Description | Time Frame |
|---|---|---|
| WOMAC: Change from the baseline of the pain subscale score at Visit 5 (Day 7 ±1 day), Visit 7 (Day 21 ±3 days) and Visit 8 (Day 28 ±3 days) | 28 days (±3 days) | |
| WOMAC: Change from the baseline of the subscale scores for stiffness and physical function at Visit 5, Visit 6, Visit 7 and Visit 8 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mr. Kenichi Furuta | Hisamitsu Pharmaceutical Co., Inc. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hisamitsu Investigator Site | Birmingham | Alabama | 35242 | United States | ||
| Hisamitsu Investigator Site |
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo Patch | Other | 2 topical placebo patches applied once daily for 28 days |
|
|
| 28 days (±3 days) |
| WOMAC: Change from the baseline of the composite score at Visit 5, Visit 6, Visit 7 and Visit 8 | 28 days (±3 days) |
| Pain Intensity differences at rest, on motion and of overall assessment using a VAS scale at each follow-up assessments time point through Day 28. | 28 days |
| Subject's Global Assessment at Visit 6 and Visit 8 | 28 days (±3 days) |
| Investigator's Global Assessment at Visit 6 and Visit 8 | 28 days (±3 days) |
| Chandler |
| Arizona |
| 85225 |
| United States |
| Hisamitsu Investigator Site | Peoria | Arizona | 85381 | United States |
| Hisamitsu Investigator Site | San Diego | California | 92108 | United States |
| Hisamitsu Investigator Site | Colorado Springs | Colorado | 80910 | United States |
| Hisamitsu Investigator Site | Denver | Colorado | 80204 | United States |
| Hisamitsu Investigator Site | Denver | Colorado | 80209 | United States |
| Hisamitsu Investigator Site | Daytona Beach | Florida | 32117 | United States |
| Hisamitsu Investigator Site | Delray Beach | Florida | 33484 | United States |
| Hisamitsu Investigator Site | Fort Myers | Florida | 33916 | United States |
| Hisamitsu Investigator Site | Pembroke Pines | Florida | 33024 | United States |
| Hisamitsu Investigator Site | Evansville | Indiana | 47714 | United States |
| Hisamitsu Investigator Site | Crestview Hills | Kentucky | 41017 | United States |
| Hisamitsu Investigator Site | Fall River | Massachusetts | 02720 | United States |
| Hisamitsu Investigator Site | Omaha | Nebraska | 68114 | United States |
| Hisamitsu Investigator Site | Las Vegas | Nevada | 89104 | United States |
| Hisamitsu Investigator Site | Reno | Nevada | 89502 | United States |
| Hisamitsu Investigator Site | Albuquerque | New Mexico | 87102 | United States |
| Hisamitsu Investigator Site | Greensboro | North Carolina | 27401 | United States |
| Hisamitsu Investigator Site | Bismarck | North Dakota | 58503 | United States |
| Hisamitsu Investigator Site | Cincinnati | Ohio | 45227 | United States |
| Hisamitsu Investigator Site | Columbus | Ohio | 43212 | United States |
| Hisamitsu Investigator Site | Mogadore | Ohio | 44260 | United States |
| Hisamitsu Investigator Site | Zanesville | Ohio | 43701 | United States |
| Hisamitsu Investigator Site | Oklahoma City | Oklahoma | 73109 | United States |
| Hisamitsu Investigator Site | Tulsa | Oklahoma | 74136 | United States |
| Hisamitsu Investigator Site | Warwick | Rhode Island | 02886 | United States |
| Hisamitsu Investigator Site | Anderson | South Carolina | 29621 | United States |
| Hisamitsu Investigator Site | Austin | Texas | 78752 | United States |
| Hisamitsu Investigator Site | San Antonio | Texas | 78217 | United States |
| Hisamitsu Investigator Site | San Antonio | Texas | 78232 | United States |
| Hisamitsu Investigator Site | Salt Lake City | Utah | 84107 | United States |
| Hisamitsu Investigator Site | Arlington | Virginia | 22205 | United States |
| Hisamitsu Investigator Site | Charlottesville | Virginia | 22911 | United States |
| Hisamitsu Investigator Site | Newport News | Virginia | 23606 | United States |
| Hisamitsu Investigator Site | Yakima | Washington | 98902 | United States |
| ID | Term |
|---|---|
| D020370 | Osteoarthritis, Knee |
| D010146 | Pain |
| D001168 | Arthritis |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided